mesalamine has been researched along with acetaminophen in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Briggs, D; Calder, I; Tange, J; Woods, R | 1 |
| Almeida, LM; Dinis, TC; Maderia, VM | 1 |
| Halliwell, B; Kaur, H; Whiteman, M | 1 |
| Alarcón, A; Martínez, JG; Morey, A; Saus, C | 1 |
| Kleinebudde, P; Thommes, M | 1 |
| Hasezaki, T; Isoda, K; Kondoh, M; Li, X; Tsutsumi, Y; Watari, A; Yagi, K | 1 |
| Ishida, I; Isoda, K; Nozawa, T; Tezuka, M | 1 |
| Bendezú García, RA; Hernández Martínez, A; Lázaro Sáez, M; Patrón Román, GO | 1 |
| Benyerbah, N; Ispas-Szabo, P; Mateescu, MA; Sakeer, K | 1 |
| Al-Gousous, J; Amidon, GE; Amidon, GL; Bermejo, M; Blechar, JA; Job, NM; Langguth, P; Lipka, E; Loebenberg, R; Ruan, H; Salehi, N; Sun, KX | 1 |
2 review(s) available for mesalamine and acetaminophen
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for mesalamine and acetaminophen
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat.
Topics: Acetaminophen; Aminophenols; Aminosalicylic Acids; Analgesics; Animals; Aspirin; Genetic Carrier Screening; Homozygote; Kidney; Kidney Diseases; Male; Mesalamine; Rats; Rats, Gunn; Rats, Mutant Strains | 1982 |
Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers.
Topics: Acetaminophen; Aminosalicylic Acids; Animals; Bepridil; Biphenyl Compounds; Dose-Response Relationship, Drug; Fatty Acids; Fatty Acids, Unsaturated; Ferrozine; Free Radical Scavengers; Free Radicals; Iron; Lipid Peroxidation; Mesalamine; Oxidation-Reduction; Oxygen Consumption; Peroxides; Picrates; Rabbits; Salicylates; Salicylic Acid; Sarcoplasmic Reticulum; Thiobarbituric Acid Reactive Substances | 1994 |
Protection against peroxynitrite dependent tyrosine nitration and alpha 1-antiproteinase inactivation by some anti-inflammatory drugs and by the antibiotic tetracycline.
Topics: Acetaminophen; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Flufenamic Acid; Free Radical Scavengers; Humans; Mesalamine; Nitrates; Pancreatic Elastase; Penicillamine; Phenylbutazone; Tetracycline; Tyrosine | 1996 |
[Crohn's disease and renal amyloidosis. Acute renal failure].
Topics: Acetaminophen; Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Amyloidosis; Analgesics, Non-Narcotic; Aspirin; Autoimmune Diseases; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Mesalamine; Metronidazole; Renal Dialysis; Substance-Related Disorders | 2002 |
Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Topics: Acetaminophen; Carrageenan; Cellulose; Chemistry, Pharmaceutical; Drug Implants; Excipients; Mesalamine; Particle Size; Solubility; Surface Properties; Technology, Pharmaceutical; Tensile Strength; Theophylline; Water | 2006 |
Effect of 70-nm silica particles on the toxicity of acetaminophen, tetracycline, trazodone, and 5-aminosalicylic acid in mice.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Blood Urea Nitrogen; Injections, Intraperitoneal; Male; Mesalamine; Mice; Mice, Inbred BALB C; Nanoparticles; Selective Serotonin Reuptake Inhibitors; Silicon Dioxide; Tetracycline; Trazodone | 2011 |
Toxicity of 50-nm polystyrene particles co-administered to mice with acetaminophen, 5-aminosalicylic acid or tetracycline.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Blood Urea Nitrogen; Male; Mesalamine; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polystyrenes; Tetracycline | 2014 |
[Chemical proctitis due to ergotamine: «not always an ulcerative colitis»].
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diagnosis, Differential; Ergotamine; Gastrointestinal Hemorrhage; Humans; Ischemia; Male; Mesalamine; Migraine Disorders; Proctitis; Rectum; Suppositories; Vasoconstriction | 2015 |
Ampholytic starch excipients for high loaded drug formulations: Mechanistic insights.
Topics: Acetaminophen; Aspirin; Drug Compounding; Excipients; Mesalamine; Metformin; Starch; Tablets; Viscosity | 2018 |
Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications.
Topics: Acetaminophen; Bicarbonates; Buffers; Capsules; Chemistry, Pharmaceutical; Drug Liberation; Excipients; Humans; Hydrogen-Ion Concentration; Hypromellose Derivatives; Intestinal Mucosa; Intestine, Small; Mesalamine; Models, Chemical; Solubility | 2019 |